PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2019; 03(01): 019-022
DOI: 10.1055/s-0039-1685242
Original Article
Indian Society of Vascular and Interventional Radiology

National Multicenter and Multiyear Review of Complications Following Fluoroscopic Gastrostomy in Patients Covered by Medicare and Medicaid

Syed I. Khalid
1   Division of Vascular and Interventional Radiology, Rush University Medical Center, Chicago, Illinois, United States
,
Rita Wu
2   Chicago Medical School, North Chicago, Illinois, United States
,
Jordan C. Tasse
1   Division of Vascular and Interventional Radiology, Rush University Medical Center, Chicago, Illinois, United States
,
David M. Tabriz
1   Division of Vascular and Interventional Radiology, Rush University Medical Center, Chicago, Illinois, United States
,
Sreekumar Madassery
1   Division of Vascular and Interventional Radiology, Rush University Medical Center, Chicago, Illinois, United States
,
Ulku C. Turba
1   Division of Vascular and Interventional Radiology, Rush University Medical Center, Chicago, Illinois, United States
,
Bulent Arslan
1   Division of Vascular and Interventional Radiology, Rush University Medical Center, Chicago, Illinois, United States
› Author Affiliations
Further Information

Address for correspondence

Syed I. Khalid, MD
Division of Interventional Radiology, Rush University Medical Center
Professional Building, 1725 W. Harrison St., Suite 450, Chicago, IL 60612
United States   

Publication History

Received: 20 December 2018

Accepted after revision: 06 February 2019

Publication Date:
23 April 2019 (online)

Also available ateRefMedOne
 
 PDF Download Permissions and Reprints

Abstract

Objective This study aims to assess the postoperative complication rates associated with fluoroscopically placed gastrostomy tubes.

Background Fluoroscopically placed gastrostomy tubes are a relatively common procedure performed by interventional radiologists. Few studies have been performed in the United States to access the complication profile of fluoroscopically placed gastrostomy tubes.

Methods Total 51 million Medicare Standard Analytic Patient Records derived from Medicare parts A and B records from 2007 to 2012 were retrospectively analyzed. Only the patients undergoing fluoroscopic gastrostomy were included in this study. Patient demographics were stratified by age, sex, comorbidities, and peri- and postoperative complications as defined by International Classification of Diseases (ICD) 9 codes.

Results Total 30,327 patients undergoing fluoroscopic gastrostomy were analyzed. Perioperative complications following these procedures were low, with 61 (0.02%) patients experiencing pneumoperitoneum, 130 (0.43%) experiencing ileus, 16 (0.05%) experiencing esophageal/gastric perforation, and 30 (0.09%) patients experiencing intra-abdominal injury. Most common postoperative complications included abdominal wall pain (n = 2,808, 9.25%), bleeding (n = 1,353, 4.46%), and mechanical complications (n = 1,435, 4.73%).

Conclusion Fluoroscopic guidance is a safe method for gastrostomy placement, with exceedingly low rates of peri- and postoperative complications.


 

Keywords

gastrostomy - G-tube - percutaneous endoscopic gastrostomy - endoscopic - fluoroscopic

Introduction

Gastrostomy tubes have been used for > 100 years in patients requiring enteral nutrition for an extended period of time.[1] Traditionally, gastrostomy tubes were placed surgically under general anesthesia in the operating room.[2] Since then, however, new techniques that are simpler to perform and require only local anesthesia such as percutaneous endoscopic insertion and fluoroscopically guided insertion have emerged and mostly displaced traditional surgery from clinical practice.[3] [4] [5] [6] [7] Early studies of both minimally invasive techniques have shown high success rates and low peri- and postoperative complication rates.[8] [9] [10] [11] However, much of the current literature on fluoroscopic gastrostomy, in particular, has been limited to being outside of the United States or performed in a single institution or region.[7] [8] [12] [13] [14] [15] [16] [17] [18] [19] This study aims to evaluate the complication rates associated fluoroscopically placed gastrostomy tubes nationally in patients covered by Medicare parts A and B in the United States.


 

Methods

Medicare Standard Analytic Files containing 100% of inpatient and outpatient facility records billed to Medicare from 2007 to 2012 were retrospectively analyzed. Total 30,327 patients were identified as having undergone fluoroscopic gastrostomy placement defined by Current Procedural Terminology (CPT) codes CPT-49440. Patients were stratified by age, sex, and comorbidities. Presence of comorbidities: diabetes mellitus (DM), hypertension (HTN), hyperlipidemia (HLD), atrial fibrillation (a-fib), obesity, history of smoking/smoker, and/or history of cancer; perioperative complications: pneumoperitoneum, ileus, esophageal and gastric perforation, and/or damage to other intra-abdominal organs; and postoperative complications: mechanical complication of gastrostomy, other gastrostomy complications, surgical site infection, necrotizing fasciitis, bleeding, ulceration, gastric outlet obstruction, colocutaneous fistula, and/or abdominal wall pain were defined by International Classification of Diseases (ICD) 9 codes (detailed in Supplementary Tables S1–S3, online only).


 

Results

Total 30,327 patients were identified as undergoing fluoroscopic gastrostomy. Regional breakdown of patients represented include 6,042 from the mid-west; 5,014 from the northeast; 12,146 from the south; 7,124 from the west; and 1 unknown with > 2,031 hospital centers represented. Age breakdown is noted ([Table 1]) with most patients age[3] 65 years (70.48%). Males made up 53.66% of the population (n = 16,272). Prevalence of comorbidities noted in patient group showed 38.81% with DM (n = 11,771), 77.16% with HTN (n = 23,401), 58.68% with HLD (n = 17,795), 23.44% with a-fib (n = 7,111), 2.27% with obesity (n = 689), 37.26% with history of smoking (n = 11,299), and 28.32% with history of cancer (n = 8,589).

Table 1

Descriptive characteristics of patients undergoing fluoroscopic gastrostomy placement

N, (%)

Total procedures

30,327

Age (y)

Unknown

274 (0.90)

≤ 64

6,224 (20.52)

65–69

5,142 (16.96)

70–74

4,782 (15.77)

75–79

4,345 (14.33)

80–84

4,278 (14.11)

≥ 85

5,282 (17.42)

Sex

Male

16,272 (53.66)

Female

13,780 (45.44)

Unknown

275 (0.91)

Comorbidities

Diabetes

11,771 (38.81)

Hypertension

23,401 (77.16)

Hyperlipidemia

17,795 (58.68)

Atrial fibrillation

7,111 (23.44)

Obesity

689 (2.27)

History of smoking

11,299 (37.26)

History of cancer

8,589 (28.32)

Incidences of perioperative complications noted showed 0.20% with pneumoperitoneum (n = 61), 0.43% with ileus (n = 130), 0.05% with esophageal/gastric perforation (n = 16), and 0.09% with intra-abdominal injury (n = 30). Incidences of 30-day postoperative complications showed 4.73% with mechanical complications (n = 1,435), 2.73% with other gastrostomy complications (n = 828), 1.46% with surgical site infection (n = 443), 0% with necrotizing fasciitis (n = 1), 4.46% with bleeding (n = 1,353), 0.06% with ulceration (n = 17), 0.30% with outlet obstruction (n = 92), 0.22% with colocutaneous fistula (n = 67), and 9.25% with abdominal wall pain (n = 2,808) ([Table 1]).


 

Discussion

Our analysis of 30,327 patients undergoing fluoroscopic gastrostomy showed low rates of perioperative complications. An early retrospective study by Hicks et al on 158 patients undergoing fluoroscopic gastrostomy reported rate of ileus large gastric residual at 4% (n = 6).[6] A later retrospective study by Neeff et al of 18 fluoroscopic gastrostomy patients reported a similar rate of ileus at 5.6% (n = 1).[13] Our study noted much lower rates of ileus with 130 (0.43%) patients only. A randomized controlled study by Cosentini et al of 44 patients undergoing fluoroscopic gastrostomy noted rate of pneumoperitoneum at 18% (n = 8).[7] Rates of perioperative esophageal/gastric perforation or other intra-abdominal injury have not been specifically reported in previous literature. Our study noted low rates of both esophageal/gastric perforation (n = 16, 0.05%) and intra-abdominal injury (n = 30, 0.09%).

Our analysis of postoperative complications following fluoroscopic gastrostomy was similarly low and mostly in concordance with reported rates in the literature. An early randomized control study of 66 patients by Hoffer et al reported five patients with mechanical failure of either tube dislodgement, fracture, leakage, or block (7.6%), five with wound infection (7.6%), none with bleeding (0%), and one with ulceration (1.5%).[8] A later retrospective study of 193 patients by Silas et al similarly reported three patients with mechanical failure of dislodgement or leakage (1.7%), four with wound infection (2.3%), and three with pain (4%).[20] Rates of postoperative complications of “other gastrostomy complications” such as tumor seeding or herniation, necrotizing fasciitis, gastric outlet obstruction, or colocutaneous fistula have not been reported in the literature history. Our findings of postoperative complications following fluoroscopic gastrostomies were comparable with 1,435 patients experiencing mechanical complications (4.73%), 828 experiencing “other gastrostomy complications” (2.73), 443 experiencing infection (1.46%), 1 experiencing necrotizing fasciitis (0%), 17 experiencing ulceration (0.06%), 92 experiencing outlet obstruction (0.030%), 67 experiencing colocutaneous fistula (0.2%), and 2,808 patients experiencing abdominal pain (9.25%).

Overall, the peri- and postoperative complication rates of fluoroscopic gastrostomies in this study are similar to those reported in the literature. Summary of the previous studies note rates of ileus at 4%[6]; rates of mechanical failure including removal, leakage, and dysfunction ranging at 1 to 6.2%[6] [8] [10] [20] [21]; rates of infection ranging at 3 to 7.6%[8] [20] [21]; rates of bleeding ranging at 0 to 3%[6] [8]; rates of ulceration at 1.5%[8]; and rates of pain at 1.6%.[20] Of note, the aforementioned studies were limited to those performed in a hospital or surgical center located in the United States only. Past studies performed outside of the United States noted interestingly higher rates of complications for mechanical failure ranging at 2.9 to 38%,[7] [13] [16] [22] rates of infection at 3 to 22%,[7] [13] [14] [15] and rates of pain at 35%,[14] though differing standards of practice and patient criteria may account for these differences. Our study showed relatively low rates of complications, with rates of abdominal pain (9.25%), bleeding (4.46%), and mechanical failure (4.73%) being the most common. Our reported rates of infection were considerably lower than those reported in the literature (1.46% in our study vs. range of 3–7.6% in the literature).

Limitations

Though the use of administrative data allows for access to large numbers of medical data files across national hospitals with long-term tracking within the coding system, analysis of such data does not allow for controls for individual procedural methods, surgeon expertise, standardization of quality of care, or insight into criteria for selection of patients. Administrative data are typically meant for administrative and financial purposes rather than research, which may subject such data to errors in accuracy and comprehensiveness due to reliance on interpretation of physician records by a medical reviewer.

Table 2

Rates of peri- and postoperative complications following fluoroscopic gastrostomy

N, (%)

Perioperative complications

Pneumoperitoneum

61 (0.20)

Ileus

130 (0.43)

Esophageal/gastric perforation

16 (0.05)

Intra-abdominal injury

30 (0.09)

Postoperative complications

Mechanical complication

1435 (4.73)

Other gastrostomy complication

828 (2.73)

Surgical site infection

443 (1.46)

Necrotizing fasciitis

1 (0)

Bleeding

1353 (4.46)

Ulceration

17 (0.06)

Gastric outlet obstruction

92 (0.30)

Colocutaneous fistula

67 (0.22)

Abdominal wall pain

2808 (9.25)

 

 

Conclusion

Fluoroscopic guidance for gastrostomy placement is a safe procedure with low rates of peri- and postoperative complications.

Institutional Approval

This study was approved by the institutional review board (IRB)—study number PDUVA001820.


 

 

 

Conflicts of Interest

No authors have conflicts to disclose.


Address for correspondence

Syed I. Khalid, MD
Division of Interventional Radiology, Rush University Medical Center
Professional Building, 1725 W. Harrison St., Suite 450, Chicago, IL 60612
United States   


  Permissions and Reprints